Advantage Investment Management’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$1K Hold
36
﹤0.01% 893
2019
Q2
$1K Hold
36
﹤0.01% 908
2019
Q1
$1K Hold
36
﹤0.01% 898
2018
Q4
$1K Hold
36
﹤0.01% 960
2018
Q3
$2K Hold
36
﹤0.01% 943
2018
Q2
$2K Hold
36
﹤0.01% 871
2018
Q1
$2K Hold
36
﹤0.01% 914
2017
Q4
$2K Hold
36
﹤0.01% 922
2017
Q3
$2K Hold
36
﹤0.01% 945
2017
Q2
$2K Hold
36
﹤0.01% 966
2017
Q1
$3K Hold
36
﹤0.01% 867
2016
Q4
$2K Hold
36
﹤0.01% 854
2016
Q3
$2K Hold
36
﹤0.01% 831
2016
Q2
$3K Hold
36
﹤0.01% 754
2016
Q1
$2K Hold
36
﹤0.01% 778
2015
Q4
$3K Hold
36
﹤0.01% 741
2015
Q3
$3K Hold
36
﹤0.01% 717
2015
Q2
$3K Hold
36
﹤0.01% 741
2015
Q1
$3K Hold
36
﹤0.01% 744
2014
Q4
$2K Buy
+36
New +$2.2K ﹤0.01% 709

Other funds holding MD

Advantage Investment Management's MD Position: Q3 2019 in Review

Advantage Investment Management held its Pediatrix Medical (MD) position steady in Q3 2019 at 36 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #893.

Advantage Investment Management first reported a position in MD in Q4 2014 and has held it in 20 quarters since. The position peaked at $3K in Q1 2017. 223 funds tracked by Wall St. Rank hold MD as of Q3 2019.

  • Advantage Investment Management held 36 shares of Pediatrix Medical worth $1K as of Q3 2019.
  • Advantage Investment Management left its Pediatrix Medical share count unchanged in Q3 2019.
  • Pediatrix Medical made up ﹤0.01% of Advantage Investment Management's portfolio in Q3 2019, its #893 holding.
  • Advantage Investment Management first reported a position in Pediatrix Medical in Q4 2014 and has held it in 20 quarters since.
  • Advantage Investment Management's Pediatrix Medical position peaked at $3K in Q1 2017.
  • 223 funds tracked by Wall St. Rank held Pediatrix Medical as of Q3 2019.

Based on Advantage Investment Management's 13F filing for Q3 2019, filed 8 Oct 2019.